Rockville-based BeneVir Biopharm Inc., a biotech specializing in immunotherapy treatments for cancer, has reached a deal to sell to pharmaceutical goliath Janssen Biotech Inc., a Johnson & Johnson company, in a deal worth up to $1.04 billion.
{iframe}https://www.bizjournals.com/washington/news/2018/05/08/md-biotech-to-be-acquired-by-new-jersey.html{/iframe}